Valued Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$167K Buy
657
+2
+0.3% +$466 0.06% 53
2026
Q1
$160K Buy
655
+47
+8% +$10.9K 0.06% 49
2025
Q4
$126K Buy
608
+50
+9% +$9.89K 0.06% 54
2025
Q3
$104K Buy
558
+17
+3% +$2.91K 0.05% 57
2025
Q2
$82.6K Sell
541
-146
-21% -$22.4K 0.04% 62
2025
Q1
$114K Sell
687
-4
-0.6% -$626 0.07% 52
2024
Q4
$100K Sell
691
-148
-18% -$22.9K 0.06% 55
2024
Q3
$136K Buy
839
+266
+46% +$42.4K 0.09% 41
2024
Q2
$83.7K Sell
573
-17
-3% -$2.53K 0.06% 51
2024
Q1
$93.3K Buy
590
+86
+17% +$13.7K 0.07% 42
2023
Q4
$78.5K Buy
+504
New +$77.3K 0.07% 37

Other funds holding JNJ

Valued Wealth Advisors's JNJ Position: Q2 2026 in Review

Valued Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 0.31% in Q2 2026, buying an estimated $466 and bringing the position to 657 shares worth $167K. The position accounts for 0.06% of the portfolio, ranked #53.

Valued Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Valued Wealth Advisors held 657 shares of Johnson & Johnson worth $167K as of Q2 2026.
  • Valued Wealth Advisors bought 2 Johnson & Johnson shares in Q2 2026, an estimated $466.
  • Johnson & Johnson made up 0.06% of Valued Wealth Advisors's portfolio in Q2 2026, its #53 holding.
  • Valued Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.